6-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)imidazo[1,2-a]pyridine, 95.0%, 1g

8-Methyl-1,2,3,4-tetrahydroquinoline, 95.0%, 1g

6-Methyl-1,3-dihydrofuro[3,4-c]pyridin-7-ol hydrochloride, 95.0%, 250mg

L(+)-tartaric acid, min. 99.5%, Ph.Eur., 500 g, plastic packaging.

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-2-methylnon-8-enoic acid, 95%, 1g

2-(Acetylamino)-3-(phenylthio)propanoic acid, 97.0%, 250mg

Vonoprazan, 98%, 100mg

But-3-en-2-yl acetate, 97%, 5g

(S)-3-((tert-Butoxycarbonyl)amino)-4-(4-cyanophenyl)butanoic acid, 95%, 250mg

1,4-Dioxa-8-aza-spiro[4.5]decan-7-one, 97%, 100mg

5-Cyclopropyl-2-methoxynicotinaldehyde, 95.0%, 100mg

1-(4-Methoxybenzyl)-1H-pyrrole-2,5-dione, 95.0%, 10g

cis-4-(Methoxycarbonyl)cyclohexanecarboxylic acid, 97%, 25g